Literature DB >> 16572924

Synthesis and preliminary screening of carbohydrazides and hydrazones of pyrrole derivatives as potential tuberculostatics.

Atanas Bijev1.   

Abstract

Five carbohydrazides and 19 hydrazones of carboxylic acids of pyrrole were synthesized as new structural analogs of known tuberculostatics, such as isoniazid (CAS 54-85-3) and its popular hydrazones. The preliminary screening against Mycobacterium tuberculosis H37Rv (ATCC 27294) at 6.25 microg/mL in 12B medium using a broth microdilution assay, the Microplate Alamar Blue Assay (MABA) registered higher inhibitory activity within the hydrazones series (up to 68 % inhibition) compared with that of the carbohydrazides (0-34 %). No simple relationship between the activity of a particular hydrazone and that of the parent carbohydrazide, or correlations with the structural features introduced by the carbonyl partner could be observed. So both most active hydrazones diethyl 5-(2-[(2,4-dimethyl-1H-3-pyrrolyl)carbonyl]hydrazonomethyl)-3-methyl-1H-2,4-pyrroledicarboxylate (22, 68 % inhibition) and ethyl 5-(4-chlorophenyl)-2-methyl-1-(2-2-1-(5-nitro-2-furyl)methylidene]hydrazino-2-oxoethyl)-1H-3-pyrrolecarboxylate (32, 55 %) originated from inactive carbohydrazides (1, 0 % and 7, 10 % respectively); ethyl 1-(2-2-[1-(3-ethoxy-4-hydroxyphenyl) methylidene] hydrazino-2-oxoethyl)-2-methyl-5-(4-nitrophenyl)-1H-3-pyrrolecarboxylate (30) showed 0 % inhibition, although derived from a hydrazide with 34 % activity. The condensation of six carbohydrazides with the same carbonyl reagent 5-nitrofurfural yielded hydrazones whose activity covered the wide range of 0-55 % inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572924     DOI: 10.1055/s-0031-1296708

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  1 in total

1.  1H-Pyrrole-2-carbohydrazide.

Authors:  Lina Wang; Xiangrong Liu; Chun Yang; Shunsheng Zhao; Kanshe Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.